GWAS meta-analysis identifies five susceptibility loci for endometrial cancer.
Ramachandran D, Wang X, Laisk T, Zheng Y, Ingold N, Canson DM, Kho PF, Naumann BJ, Chapman CJ, Bousset K, Krause AV, Schürmann P, Wieland B, Hanel P, Hülse F, Häfner N, Runnebaum I, Dubrowinskaja N, Turmanov N, Yugay T, Yessimsiitova ZB, Amant F, Annibali D, Beckmann MW, Bodelon C, Buchanan DD, Chen C, Clarke MA, Cook LS, De Vivo I, De Wispelaere W, Du M, Easton DF, Emons J, Fasching PA, Friedenreich CM, Gallagher G, Giles GG, Goode EL, Harris HR, Hunter DJ, Kolin DL, Kraft P, Lacey JV, Lambrechts D, Lu L, Mutter GL, Naduparambil J, O'Connell K, Patel AV, Pharoah PDP, Rebbeck TR, Ricceri F, Risch HA, Ruebner M, Sacerdote C, Scott RJ, Setiawan VW, Shu XO, Southey MC, Tham E, Tomlinson I, Turman C, Wentzensen N, Xu W, Yu H, Zheng W, Spurdle AB, Yarden Y; Estonian Biobank Research Team; Mägi R, Hillemanns P, Glubb DM, Dörk T, O'Mara TA.
Ramachandran D, et al. Among authors: easton df.
EBioMedicine. 2025 Jul 8;118:105830. doi: 10.1016/j.ebiom.2025.105830. Online ahead of print.
EBioMedicine. 2025.
PMID: 40633141
Free PMC article.